Orchard Therapeutics to Webcast Conference Call of 2018 Financial Results on March 21, 2019
A live webcast of the presentation will be available under "News & Events" in the Investors & Media section of the company's website at orchard-tx.com. A replay of the webcast will be archived on the Orchard website following the presentation. The conference call can be accessed by dialing 1-866-930-5155 (domestic) or 1-409-937-8974 (international) and referring to conference ID 2279788. The webcast will be archived and made available for replay on the company's website beginning approximately two hours after the event.
About Orchard
Orchard’s portfolio of autologous, ex vivo, hematopoietic stem cell gene therapies includes Strimvelis, the first such treatment approved by the
Orchard currently has offices in the
Contacts
Corporate & Investor contact
Director, Investor Relations
+1 862-242-0764
Renee.Leck@orchard-tx.com
Media contact
LifeSci Public Relations
+1 516-655-0842
Allison@lifescipublicrelations.com
Source: Orchard Therapeutics Limited